Micron Technology
MU
NVIDIA
NVDA
Intel
INTC
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
ALXO ALX Oncology
- 1.620
- +0.140+9.46%
Close Dec 20 16:00 ET
- 1.620
- -0.001-0.03%
Post 20:01 ET
85.44MMarket Cap-0.55P/E (TTM)
1.670High1.510Low2.17MVolume1.510Open1.480Pre Close3.48MTurnover6.16%Turnover RatioLossP/E (Static)52.74MShares17.82552wk High0.62P/B56.91MFloat Cap1.19052wk Low--Dividend TTM35.13MShs Float117.450Historical High--Div YieldTTM10.81%Amplitude1.190Historical Low1.606Avg Price1Lot Size
ALX Oncology News
Jefferies Downgrades ALX Oncology(ALXO.US) to Hold Rating, Cuts Target Price to $2
Sector Update: Health Care Stocks Decline Late Afternoon
Sector Update: Health Care
Top Midday Decliners
ALX Oncology Shares Fall After Downgrade From Jefferies
Express News | ALX Oncology Holdings Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $2 From $12
Cantor Fitzgerald Reiterates Overweight on ALX Oncology Holdingsto Overweight
ALX Oncology to Present Updated Results From Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients With HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium
ALX Oncology Price Target Maintained With a $25.00/Share by HC Wainwright & Co.
ALX Oncology Holdings Analyst Ratings
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024
ALX Oncology Announces New Data Demonstrating Evorpacept in Combination With Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer
ALX Oncology to Participate in the Piper Sandler 36th Annual Healthcare Conference
ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Press Release: ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer
Cantor Fitzgerald Reiterates Overweight on ALX Oncology Holdings
LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating
ALX Oncology Highlights Promising Trial Results
Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Maintains Target Price $3
Stifel Nicolaus Sticks to Its Hold Rating for ALX Oncology Holdings (ALXO)
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.